Product description

Our streamlined approach to developing drug substance has been shown to reduce manufacturing costs by 50% from preclinical to Phase I.  To best support our customer’s needs, we have made significant investments in technologies and equipment to meet the increasing demand for complex small-scale drug substance manufacture. With more than 40 years of experience in synthetic organic chemistry coupled with extensive expertise in flow chemistry, synthetic biology and biocatalysis, we can optimize manufacturing processes and save months of development time for our customers. 

- Process Research and Development- Solid State Services

- Capabilities include:
- Salt Selection:
- Polymorph Screening- Amorphous Dispersions- Crystallization Development
- Solid State Characterization:
- X-Ray powder diffraction (XRPD)
- Theral Analysis (DSC, TGA)
- Hygroscopy (DVS)Hot stage microscopy
- Particle size distribution and particle enumeration
- Surface Area
- Solution and Solid State NMRFT-IR
- Dissolution/disintegration
Read more

Specifications

Sales markets North America (USA, Canada); Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries
Supplied from United Kingdom; United States

More products from QUOTIENT SCIENCES LIMITED

View all our products (15)
Wavelength Pharmaceuticals

Wavelength Pharmaceuticals

Your trusted end-to-end CDMO partner

Your trusted end-to-end CDMO partner

Gerresheimer is the global go-to partner for medicine packaging and drug delivery devices with the broad product range for pharma, health, wellbeing and biotech.

Gerresheimer is the global go-to partner for medicine packagin...

Making a Material Difference

Making a Material Difference

Savior Lifetec. Co., the most qualified Carbapenem manufacture in world

Savior Lifetec. Co., the most qualified Carbapenem manufacture...